Aluminum-containing deodorant safe for patients with breast cancer undergoing radiotherapy
the ONA take:
According to a recent study published in the International Journal of Radiation Oncology*Biology*Physics, researchers from Curtin University in Perth, Western Australia, have found that women undergoing radiotherapy for breast cancer can use deodorant without the deodorant increasing risk of underarm skin reactions, pain, itching, or burning.
Most women undergoing radiation therapy will develop a skin reaction, but researchers sought to investigation whether deodorant increased that risk.
For the study, researchers enrolled 333 women with breast cancer undergoing similar radiotherapy regimens and assigned them to use soap, aluminum-containing deodorant and soap, or non-aluminum-containing deodorant and soap.
Results showed that there were similar levels of underarm skin reaction, burning, itching, and pain across all three groups, but participants who used aluminum-containing deodorant experienced 85% less sweating.
Women are still advised not to use deodorant while receiving radiation treatment, but now these findings suggest that deodorant use during radiotherapy does not exacerbate underarm skin reactions.
Women undergoing radiotherapy for breast cancer can use deodorant without increasing risk of underarm skin reactions, pain, itching, or burning.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Neuropathic Cancer Pain Linked to Reduced Quality of Life
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|